Literature DB >> 2510716

Effect of phorbol ester treatment on receptor-mediated versus G-protein-activator-mediated responses in platelets. Evidence for a two-site action of phorbol ester at the level of G-protein function.

S Krishnamurthi1, C P Wheeler-Jones, V V Kakkar.   

Abstract

In platelets, and in several other cell systems, pre-treatment with protein kinase C activators such as phorbol 12-myristate 13-acetate (PMA) results in the inhibition of receptor-mediated responses, suggesting that protein kinase C may play an important role in the termination of signal transduction. In the present study, we have attempted to locate the site of action of phorbol ester by comparing thrombin-induced (i.e. receptor-mediated) platelet activation with that induced by guanosine 5'-[gamma-thio]triphosphate (GTP[S]) and NaF, two agents which by-pass the receptor and initiate platelet responses by directly modulating G-protein function. After a 10 s pre-treatment with PMA (16 nM), dense-granule secretion induced by thrombin (0.2 unit/ml), GTP[S] (40 microM) and NaF (30 mM) was potentiated, resulting in a greater than additive response to agent plus PMA. However, after a 5 min pre-treatment, thrombin-induced secretion alone was inhibited, whereas PMA plus GTP[S]/NaF-induced release remained greater than additive. [32P]Phosphatidate formation in response to all three agents, in contrast, was inhibited by 50-70% in PMA (5 min)-treated platelets. That secretion induced by these agents is a protein kinase C-dependent event was demonstrable by using staurosporine, a protein kinase C inhibitor which at concentrations of 1-10 nM inhibited (70-90%) PMA-induced as well as thrombin- and NaF-induced secretion and protein phosphorylation. In membranes from PMA-treated platelets, thrombin-stimulated GTPase activity was significantly enhanced compared with that in untreated membranes (59% versus 82% increase over basal activity). The results suggest that inhibition of receptor-mediated responses by PMA may be directed towards two sites relating to G-protein activation: (i) receptor-stimulated GTPase activity and (ii) G-protein-phospholipase C coupling. Furthermore, the lack of inhibition of NaF- and GTP[S]-induced secretion by PMA suggests that different mechanisms may be involved in thrombin-induced and G-protein-activator-induced secretion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510716      PMCID: PMC1133231          DOI: 10.1042/bj2620077

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Effects of guanine nucleotides on the properties of 5-hydroxytryptamine secretion from electropermeabilised human platelets.

Authors:  D E Knight; M C Scrutton
Journal:  Eur J Biochem       Date:  1986-10-01

2.  Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase.

Authors:  T Katada; A G Gilman; Y Watanabe; S Bauer; K H Jakobs
Journal:  Eur J Biochem       Date:  1985-09-02

3.  Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.

Authors:  T Tamaoki; H Nomoto; I Takahashi; Y Kato; M Morimoto; F Tomita
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

4.  Modulation of adenylate cyclase of human platelets by phorbol ester. Impairment of the hormone-sensitive inhibitory pathway.

Authors:  K H Jakobs; S Bauer; Y Watanabe
Journal:  Eur J Biochem       Date:  1985-09-02

5.  Two roles for guanine nucleotides in the stimulus-secretion sequence of neutrophils.

Authors:  M M Barrowman; S Cockcroft; B D Gomperts
Journal:  Nature       Date:  1986 Feb 6-12       Impact factor: 49.962

6.  Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni.

Authors:  M D Houslay; D Bojanic; A Wilson
Journal:  Biochem J       Date:  1986-03-15       Impact factor: 3.857

Review 7.  Studies and perspectives of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

8.  1,2-Dioctanoylglycerol but not 1-oleoyl-2-acetylglycerol inhibits agonist-induced platelet responses. Dependence of effects on extent of 45-kDa protein phosphorylation and agonist type.

Authors:  S Krishnamurthi; S Joseph; V V Kakkar
Journal:  Eur J Biochem       Date:  1987-09-15

9.  Metabolic and functional consequences of introducing inositol 1,4,5-trisphosphate into saponin-permeabilized human platelets.

Authors:  K S Authi; B J Evenden; N Crawford
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

10.  Synergistic potentiation of 5-hydroxytryptamine secretion by platelet agonists and phorbol myristate acetate despite inhibition of agonist-induced arachidonate/thromboxane and beta-thromboglobulin release and Ca2+ mobilization by phorbol myristate acetate.

Authors:  S Krishnamurthi; S Joseph; V V Kakkar
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

View more
  5 in total

Review 1.  Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins.

Authors:  T A Fields; P J Casey
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

2.  Identification of 14-3-3 proteins in human platelets: effects of synthetic peptides on protein kinase C activation.

Authors:  C P Wheeler-Jones; M P Learmonth; H Martin; A Aitken
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

3.  Okadaic acid inhibits activation of phospholipase C in human platelets by mimicking the actions of protein kinases A and C.

Authors:  T R Walker; S P Watson
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

4.  The role of the phosphatidylinositol turnover in 12-hydroxyeicosatetraenoic acid generation from human platelets by Escherichia coli alpha-haemolysin, thrombin and fluoride.

Authors:  B König; W König
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

5.  Mastoparan promotes exocytosis and increases intracellular cyclic AMP in human platelets. Evidence for the existence of a Ge-like mechanism of secretion.

Authors:  C P Wheeler-Jones; T Saermark; V V Kakkar; K S Authi
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.